FACIAL NERVE DISORDER side effect
What is FACIAL NERVE DISORDER ?FACIAL NERVE DISORDER : Cosopt Side Effects Report #5624757-7
Physician from TUNISIA reported COSOPT problem on Feb 07, 2008. Female patient, 30 years of age, was diagnosed with post procedural complication and was treated with COSOPT. After drug was administered, patient experienced the following problems/side effects: convulsion, facial nerve disorder, neuralgia, paraesthesia, . COSOPT dosage: unknown. During the same period patient was treated with SOLUPRED, MAXIDROL, TROPICAMIDE, OFLOXACIN. Patient recovered.
FACIAL NERVE DISORDER : Sandimmune Side Effects Report #5442987-4
SANDIMMUNE problem was reported by a Physician from GERMANY on Aug 28, 2007. Female patient was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: depression, facial nerve disorder, intestinal perforation, menstrual disorder, non-hodgkin's lymphoma, oedema, portal shunt, sinusitis, small intestinal resection, . SANDIMMUNE dosage: unknown. During the same period patient was treated with FLUOXETINE, DOPASTON. Patient was hospitalized. Patient recovered.
FACIAL NERVE DISORDER : Natalizumab Side Effects Report #5397315-X
Physician from GREECE reported NATALIZUMAB problem on July 13, 2007. Female patient, 33 years of age, weighting 127.9 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysarthria, facial nerve disorder, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
FACIAL NERVE DISORDER : Natalizumab Side Effects Report #5397315-X
NATALIZUMAB problem was reported by a Physician from GREECE on July 13, 2007. Female patient, 33 years of age, weighting 127.9 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysarthria, facial nerve disorder, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.